Medications

Ketamine-based nasal spray to treat depression

The FDA recently approved a ketamine-based drug to assist with treating depression. The new medication, Spravato, is an intranasal spray that can help those suffering with extreme depression who see little results with psychiatric ...

Psychology & Psychiatry

Study reveals a new target for developing treatments for depression

A new CAMH study shows for the first time that people experiencing clinical depression have higher levels of a brain protein called MAO-B. The finding—published online today in JAMA Psychiatry - opens the door to a new ...

Psychology & Psychiatry

Integrated therapy treating obesity and depression is effective

An intervention combining behavioral weight loss treatment and problem-solving therapy with as-needed antidepressant medication for participants with co-occurring obesity and depression improved weight loss and depressive ...

Medications

BDNF–VEGF interplay key to rapid antidepressant actions

A study by researchers at Yale University reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine. The study, published in Biological Psychiatry, reports ...

Psychology & Psychiatry

Benzodiazepines may decrease mortality in congestive heart failure

A study published in the current issue of Psychotherapy and Psychosomatics indicates that treatment of anxiety with benzodiazepines may improve survival in congestive heart failure. Depression (in various forms and as various ...

page 10 from 40